Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery

June 30, 2022 updated by: Huifang Jiang, Zhejiang Cancer Hospital

Ultrasound-guided Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament Versus Thoracic Epidural Analgesia After Open Liver Surgery: A Prospective, Randomized, Controlled, Noninferiority Trial

This is a prospective, randomized, controlled, noninferiority trial for evaluating the efficacy of ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament versus thoracic epidural analgesia after open liver surgery.

Study Overview

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310022
        • Zhejiang Cancer Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age≥18 years
  • ASA I-III
  • Open liver surgery

Exclusion Criteria:

  • Contraindication to nerve block or epidural puncture
  • Chronic use of opioids or NSAIDs
  • Refused to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Quadratus lumborum block
Ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament.
Bilateral single-injection 20 ml 0.56% ropivacaine. Intravenous analgesia was started postoperatively and consisted of 1ug/ml sufentanil,2 ml/h with a 5-minute lockout period, a limited 12 ml/h dose.
Active Comparator: Thoracic epidural analgesia
Thoracic epidural analgesia at the level of T7-10.
A thoracic epidural at the level of T7-10. Epidural infusion was started postoperatively and consisted of sufentanil (0.6ug/mL) and ropivacaine(0.2%) at 3ml/h.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS (numeric rating scale) score for coughing pain
Time Frame: at 24 hours after surgery
Postoperative pain was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain)
at 24 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS score for rest and coughing pain
Time Frame: at 1, 6, 24, 48, 72 hours after surgery
Postoperative pain at rest and during coughing was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain)
at 1, 6, 24, 48, 72 hours after surgery
consumption of opioid converted to IV morphine equivalents
Time Frame: during 24 hours after surgery
opioids given postoperatively converted to IV morphine equivalents
during 24 hours after surgery
Numbers of additional analgesics
Time Frame: during 72 hours after surgery
Additional rescue analgesics were used when pain relief was inadequate (NRS >3). The choice of rescue analgesic was oxydone 5-10mg.
during 72 hours after surgery
The incidence of postoperative hypotension
Time Frame: during 72 hours after surgery
Adverse reactions related to analgesia
during 72 hours after surgery
The incidence of nausea and vomiting
Time Frame: during 72 hours after surgery
Adverse reactions related to analgesia
during 72 hours after surgery
The incidence of pruritus
Time Frame: during 72 hours after surgery
Adverse reactions related to analgesia
during 72 hours after surgery
The incidence of respiratory depression
Time Frame: during 72 hours after surgery
Adverse reactions related to analgesia
during 72 hours after surgery
Time to ambulation in days
Time Frame: through study completion, an average of 2-3 days
Postoperative ambulation time
through study completion, an average of 2-3 days
Time to eat in days
Time Frame: through study completion, an average of 2-3 days
Time to start eating after surgery
through study completion, an average of 2-3 days
Time to flatus in hours
Time Frame: through study completion, an average of 40-50 hours
Time to flatus after surgery
through study completion, an average of 40-50 hours
Time to defecation in hours
Time Frame: through study completion, an average of 60-70 hours
Time to defecation after surgery
through study completion, an average of 60-70 hours
Time to urethral catheter removal in hours
Time Frame: through study completion, an average of 60-70 hours
Time tourethral catheter removal after surgery
through study completion, an average of 60-70 hours
Postoperative hospital stay in days
Time Frame: through study completion, an average of 7-8 days
The time from operation to discharge
through study completion, an average of 7-8 days
Clavien-Dindo classification (grade I, II, III, IV) for postoperative complication
Time Frame: One month after surgery
Postoperative Clavien-Dindo complication classification
One month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Huifang Jiang, M.D., Zhejiang Caner Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 17, 2020

Primary Completion (Actual)

June 2, 2021

Study Completion (Actual)

July 2, 2021

Study Registration Dates

First Submitted

December 13, 2020

First Submitted That Met QC Criteria

December 13, 2020

First Posted (Actual)

December 16, 2020

Study Record Updates

Last Update Posted (Actual)

July 6, 2022

Last Update Submitted That Met QC Criteria

June 30, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-2020-350

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Postoperative numeric rating scale (NRS) pain score at rest and during coughing at 1, 6, 24, 48 and 72 hours after surgery.

IPD Sharing Time Frame

permanent validity

IPD Sharing Access Criteria

Baidu Netdisk code:3i81

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Surgery

Clinical Trials on Ultrasound-guided anterior quadratus lumborum block at the lateral supra-arcuate ligament

3
Subscribe